Synlogic to Present at the Chardan 3rd Annual Genetic Medicines Conference
01 October 2019 - 6:02AM
Business Wire
Synlogic, Inc. (NASDAQ: SYBX) announced today that Aoife
Brennan, M.B., B.Ch., Synlogic’s president and chief executive
officer, will provide a corporate update at the Chardan 3rd Annual
Genetic Medicines Conference on Monday, October 7 at 4:15 pm ET, in
New York City.
A live webcast of the presentation can be accessed under “Event
Calendar” in the Investors & Media section of the Company’s
website. An archived copy of the webcast will be available on the
Synlogic website for approximately 30 days after the event.
About Synlogic Synlogic is pioneering the development of
a novel class of living medicines, Synthetic Biotic medicines,
based on its proprietary drug development platform. Synlogic
leverages the tools and principles of synthetic biology to
genetically engineer probiotic microbes to perform or deliver
critical functions missing or damaged due to disease. The company’s
lead program, SYNB1618, targets phenylketonuria (PKU). When
delivered orally, Synthetic Biotic medicines can act from the gut
to compensate for the dysfunctional metabolic pathway and have a
systemic effect, with the potential to significantly improve
symptoms of disease for affected patients. In addition, the company
is leveraging the broad potential of its platform to create
Synthetic Biotic medicines for the treatment of more common
diseases, including inflammatory and immune disorders, and cancer.
Synlogic is collaborating with AbbVie to develop Synthetic
Biotic-based treatments for inflammatory bowel disease (IBD). For
more information, please visit www.synlogictx.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190930005764/en/
MEDIA CONTACT: Caroline Rufo, Ph.D. MacDougall Phone:
781-235-3060 Email:crufo@macbiocom.com INVESTOR CONTACT:
Elizabeth Wolffe, Ph.D. Synlogic, Inc. Phone: 617-207-5509 Email:
liz@synlogictx.com
Synlogic (NASDAQ:SYBX)
Historical Stock Chart
From Apr 2024 to May 2024
Synlogic (NASDAQ:SYBX)
Historical Stock Chart
From May 2023 to May 2024